Comparison Of Glucagon Like Peptide/1 Levels In Diabetic Women With Ovarian Polycystic Syndrome And Healthy Women
Objective: The aim of the study is to compare Glucagon-Like Peptide-1 levels in polycystic ovarian syndrome patients having diabetes mellitus (DM) and healthy women.Polycystic ovarian syndrome (PCOS) is one of the routine endocrinological disorders of reproductive-aged women and it is associated wi...
Saved in:
Main Authors: | Namra Iqtidar, Imran Ali Zaidi, Sobia Niaz, Javaria Latif, Amir Naveed, Ayesha Yousaf |
---|---|
Format: | Article |
Language: | English |
Published: |
Rawalpindi Medical University
2024-09-01
|
Series: | Journal of Rawalpindi Medical College |
Online Access: | https://www.journalrmc.com/index.php/JRMC/article/view/2631 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study
by: Swati Dhar, et al.
Published: (2024-01-01) -
Glucagon-like peptide 1 receptor agonists in obesity treatment - a literature review
by: Aleksander Jentkiewicz, et al.
Published: (2025-02-01) -
Prevalence Of Skin Manifestations In Patients With Polycystic Ovarian Syndrome
by: Tehseen Naveed, et al.
Published: (2024-03-01) -
Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide agonists for the treatment of obesity and diabetes mellitus
by: Alexander C. Martins, et al.
Published: (2024-04-01) -
Correlation of GLUT4, LEPR , and TNF-a with endometrial receptivity in women with polycystic ovarian syndrome-induced infertility
by: Yan Dong, et al.
Published: (2025-01-01)